Simotinib
CAS No. 944258-89-3
Simotinib( SIM6802 | SIM-6802 )
Catalog No. M16764 CAS No. 944258-89-3
Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 258 | Get Quote |
|
| 50MG | 1269 | Get Quote |
|
| 100MG | 1791 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSimotinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionSimotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
-
DescriptionSimotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.Lung Cancer Phase 1 Clinical.
-
In VitroSimotinib inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases.
-
In VivoSimotinib has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model.
-
SynonymsSIM6802 | SIM-6802
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number944258-89-3
-
Formula Weight500.95
-
Molecular FormulaC25H26ClFN4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (249.53 mM)
-
SMILESCOC1=C(OCCN2CC3(C4(OCCO4)C2)CC3)C=C(C(NC5=CC=C(F)C(Cl)=C5)=NC=N6)C6=C1
-
Chemical NameN-(3-chloro-4-fluorophenyl)-6-(2-(5,8-dioxa-11-azadispiro(2.0.4.3)undec-11-yl)ethoxy)-7-methoxy-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang L, et al. Anticancer Drugs. 2016 Apr;27(4):300-11.
molnova catalog
related products
-
Tyrphostin AG 1296
Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.
-
Epidermal Growth Fac...
Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.
-
AG18
AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
Cart
sales@molnova.com